Reimbursement Working Group
Robert Dumanois
Director, Reimbursement Strategy
Thermo Fisher Scientific
Co-Chairs
Suzanne Belinson, PhD
Vice President of Commercial Markets
Tempus AI
Current Projects
Collaborating with a group of payers to draft a manuscript exploring the impact of financial toxicity in oncology, with the overall goal being to raise public awareness of operating environment challenges. The dissemination plan includes a publication, meeting presentations and panels.
Participating Organizations
Association for Molecular Pathology (AMP), Delfi Diagnostics, Exact Sciences, Guardant Health, Illumina, Johnson & Johnson, National Brain Tumor Society (NBTS), Personalis, Roche, Tempus AI, Thermo Fisher
Meetings
This working group meets on zoom once a month on Wednesday from 3:00 - 4:00 PM EST.
The co-chairs of this working group meet with a small group of payers once a month. This meeting is not open to new individuals.
Special workshops and sessions:
March 2025: hosted a fireside chat with payers at the BLOODPAC Q1 meeting.